Bioinformatics Analysis Reveals Hub Genes That May Reduce Inflammation and Complications After Cardiopulmonary Bypass
DOI:
https://doi.org/10.1532/hsf.4487Keywords:
cardiopulmonary bypassAbstract
Cardiopulmonary bypass (CPB), though indispensable in many cardiac surgery procedures, has several undesirable consequences. The aim of this study was to identify potential genes that may reduce the inflammatory response and complications after CPB. The GSE132176 dataset was selected from the Gene Expression Omnibus (GEO) database and included 10 patients with tetralogy of Fallot and 10 patients with an atrial septal defect who underwent CPB surgery. TSV files were downloaded after GEO2R processing. Protein-protein interaction analysis of common differentially expressed genes (DEGs) was performed using the Search Tool for the Retrieval of Interacting Genes. Gene modules and hub genes were visualized in the protein-protein interaction network using Cytoscape. Enrichment analysis was performed for all important DEGs, modular genes, and hub genes. A total of 72 DEGs were screened, including two functional and one hub gene module. FOS modular genes were primarily enriched in NGF-stimulated transcription, spinal cord injury, and PID AP1 pathway. The ATF3 modular gene was mainly enriched in cytomegalovirus infection and transcriptional misregulation in cancer. Hub gene modules were primarily enriched in the PID AP1 pathway, positive regulation of pri-miRNA transcription by RNA polymerase II, and the PID ATF2 pathway. FOS, JUN, ATF3, and EGR1 were the four most important hub genes; the top three hub genes were involved in the formation of AP-1 and enriched in the AP-1 pathway. Finally, we measured the expression levels of these four genes in patients undergoing CPB via qRT-PCR, and the results were consistent with those obtained in bioinformatic analysis. FOS, JUN, ATF3, and EGR1 and the AP-1 pathway may play key roles in inflammation and complications caused by CPB.
References
Aebert H, Cornelius T, Ehr T, et al. 1997. Expression of immediate early genes after cardioplegic arrest and reperfusion. Ann Thorac Surg. 63: 1669-75.
Alfonso-Jaume MA, Bergman MR, Mahimkar R, et al. 2006. Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. American Journal of Physiology-Heart and Circulatory Physiology. 291: H1838-H46.
Bhindi R, Fahmy RG, McMahon AC, Khachigian LM, Lowe HC. 2012. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion. J Pathol. 227: 157-64.
Boehne M, Sasse M, Karch A, et al. 2017. Systemic inflammatory response syndrome after pediatric congenital heart surgery: Incidence, risk factors, and clinical outcome. J Card Surg. 32: 116-25.
Cao Y, Yang Q, Deng H, et al. 2019. Transcriptional factor ATF3 protects against colitis by regulating follicular helper T cells in Peyer's patches. Proc Natl Acad Sci U S A. 116: 6286-91.
Durandy Y. 2014. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Artif Organs. 38: 11-8.
Gao FF, Jia QY, Guo FX, et al. 2009. Egr-1, a central and unifying role in cardioprotection from ischemia-reperfusion injury? Cell Physiol Biochem. 24: 519-26.
Hannemann N, Jordan J, Paul S, et al. 2017. The AP-1 Transcription Factor c-Jun Promotes Arthritis by Regulating Cyclooxygenase-2 and Arginase-1 Expression in Macrophages. J Immunol. 198: 3605-14.
Hessel EA, 2nd. 2014. A Brief History of Cardiopulmonary Bypass. Semin Cardiothorac Vasc Anesth. 18: 87-100.
Huang Z, Li H, Guo F, et al. 2009. Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats. Cell Physiol Biochem. 24: 17-24.
Jariel-Encontre I, Salvat C, Steff AM, et al. 1997. Complex mechanisms for c-fos and c-jun degradation. Mol Biol Rep. 24: 51-6.
Kang SM, Lim S, Won SJ, et al. 2011. c-Fos regulates hepatitis C virus propagation. FEBS Lett. 585: 3236-44.
Kingma JG, Jr. 1999. Cardiac adaptation to ischemia-reperfusion injury. Ann N Y Acad Sci. 874: 83-99.
Koren L, Alishekevitz D, Elhanani O, et al. 2015. ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling. International Journal of Cardiology. 198: 232-40.
Ku HC, Cheng CF. 2020. Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer. Front Endocrinol (Lausanne). 11: 556.
Leppa S, Bohmann D. 1999. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene. 18: 6158-62.
Li JK, Nie L, Zhao YP, et al. 2016. IL-17 mediates inflammatory reactions via p38/c-Fos and JNK/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cells. J Transl Med. 14: 77.
Lin H, Cheng CF. 2018. Activating transcription factor 3, an early cellular adaptive responder in ischemia/reperfusion-induced injury. Ci Ji Yi Xue Za Zhi. 30: 61-65.
Maulik N, Goswami S, Galang N, Das DK. 1999. Differential regulation of Bcl-2, AP-1 and NF-kappaB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett. 443: 331-6.
McRobb CM, Mejak BL, Ellis WC, et al. 2014. Recent Advances in Pediatric Cardiopulmonary Bypass. Semin Cardiothorac Vasc Anesth. 18: 153-60.
Paparella D, Yau TM, Young E. 2002. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 21: 232-44.
Raivich G, Behrens A. 2006. Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog Neurobiol. 78: 347-63.
Rohini M, Haritha Menon A, Selvamurugan N. 2018. Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions. Int J Biol Macromol. 120: 310-17.
Ruel M, Bianchi C, Khan TA, et al. 2003. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg. 126: 1521-30.
Sawai M, Ishikawa Y, Ota A, Sakurai H. 2013. The proto-oncogene JUN is a target of the heat shock transcription factor HSF1. Febs Journal. 280: 6672-80.
Soraya AS, Tali H, Rona S, et al. 2021. ATF3 expression in cardiomyocytes and myofibroblasts following transverse aortic constriction displays distinct phenotypes. Int J Cardiol Heart Vasc. 32: 100706.
Squiccimarro E, Labriola C, Malvindi PG, et al. 2019. Prevalence and Clinical Impact of Systemic Inflammatory Reaction After Cardiac Surgery. J Cardiothorac Vasc Anesth. 33: 1682-90.
Tanaka Y, Nakamura A, Morioka MS, et al. 2011. Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway. PLoS One. 6: e26848.
Trizzino M, Zucco A, Deliard S, et al. 2021. EGR1 is a gatekeeper of inflammatory enhancers in human macrophages. Science Advances. 7.
Trop-Steinberg S, Azar Y. 2017. AP-1 Expression and its Clinical Relevance in Immune Disorders and Cancer. Am J Med Sci. 353: 474-83.
Uluckan O, Guinea-Viniegra J, Jimenez M, Wagner EF. 2015. Signalling in inflammatory skin disease by AP-1 (Fos/Jun). Clin Exp Rheumatol. 33: S44-9.
Wang N, Verna L, Hardy S, et al. 1999. c-Jun triggers apoptosis in human vascular endothelial cells. Circ Res. 85: 387-93.
Wang NP, Pang XF, Zhang LH, et al. 2014. Attenuation of inflammatory response and reduction in infarct size by postconditioning are associated with downregulation of early growth response 1 during reperfusion in rat heart. Shock. 41: 346-54.
Wei Z, Qiao S, Zhao J, et al. 2019. miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sci. 232: 116632.
Wisdom R, Johnson RS, Moore C. 1999. C-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18: 188-97.
Wu H, Lei S, Yuan J, et al. 2013. Ischemic postconditioning downregulates Egr-1 expression and attenuates postischemic pulmonary inflammatory cytokine release and tissue injury in rats. J Surg Res. 181: 204-12.
Yan SF, Harja E, Andrassy M, Fujita T, Schmidt AM. 2006. Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis. J Am Coll Cardiol. 48: A47-55.
Yeh KY, Yeh M, Glass J, Granger DN. 2000. Rapid activation of NF-kappaB and AP-1 and target gene expression in postischemic rat intestine. Gastroenterology. 118: 525-34.
Zhang Y, Shi G, Zheng J, et al. 2008. The protective effect of Egr-1 antisense oligodeoxyribonucleotide on myocardial injury induced by ischemia-reperfusion and hypoxia-reoxygenation. Cell Physiol Biochem. 22: 645-52.
Zhou Y, Shi G, Zheng J, et al. 2010. The protective effects of Egr-1 antisense oligodeoxyribonucleotide on cardiac microvascular endothelial injury induced by hypoxia-reoxygenation. Biochem Cell Biol. 88: 687-95.
Zhu XY, Yan XH, Chen SJ. 2008. H(2)S protects myocardium against ischemia/reperfusion injury and its effect on c-Fos protein expression in rats. Sheng Li Xue Bao. 60: 221-7.
